270 related articles for article (PubMed ID: 32456571)
1. Expression of ACAP1 Is Associated with Tumor Immune Infiltration and Clinical Outcome of Ovarian Cancer.
Zhang J; Zhang Q; Zhang J; Wang Q
DNA Cell Biol; 2020 Sep; 39(9):1545-1557. PubMed ID: 32456571
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
Wang N; Zhu L; Xu X; Yu C; Huang X
Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication and immunological characterisation of the ARF-GEF family member CYTH4 in ovarian cancer.
Zhang Q; Wang Q; Wu S; Zhang J
Autoimmunity; 2020 Dec; 53(8):434-442. PubMed ID: 33078956
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and immunological characterization of RNA m
Wang Q; Zhang Q; Li Q; Zhang J; Zhang J
Mol Genet Genomic Med; 2021 Jan; 9(1):e1547. PubMed ID: 33225598
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights into regulated cargo binding by ACAP1 protein.
Bai M; Pang X; Lou J; Zhou Q; Zhang K; Ma J; Li J; Sun F; Hsu VW
J Biol Chem; 2012 Aug; 287(34):28675-85. PubMed ID: 22645133
[TBL] [Abstract][Full Text] [Related]
6. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Arf6 and ACAP1 signaling by the PTB-domain-containing adaptor protein GULP.
Ma Z; Nie Z; Luo R; Casanova JE; Ravichandran KS
Curr Biol; 2007 Apr; 17(8):722-7. PubMed ID: 17398097
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of phosphoinositides and BAR domain proteins in endosomal tubulation.
Shinozaki-Narikawa N; Kodama T; Shibasaki Y
Traffic; 2006 Nov; 7(11):1539-50. PubMed ID: 17010122
[TBL] [Abstract][Full Text] [Related]
9. Association Between Succinate Receptor SUCNR1 Expression and Immune Infiltrates in Ovarian Cancer.
Zhang J; Zhang Q; Yang Y; Wang Q
Front Mol Biosci; 2020; 7():150. PubMed ID: 33062639
[TBL] [Abstract][Full Text] [Related]
10. ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors.
Yi Q; Pu Y; Chao F; Bian P; Lv L
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497434
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Life Sci; 2021 Jul; 277():119461. PubMed ID: 33811900
[TBL] [Abstract][Full Text] [Related]
12. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
13. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the immune microenvironment in ovarian cancer patients.
Yang L; Wang S; Zhang Q; Pan Y; Lv Y; Chen X; Zuo Y; Hao D
Mol Omics; 2018 Oct; 14(5):341-351. PubMed ID: 30129640
[TBL] [Abstract][Full Text] [Related]
15. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
16. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
17. ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
Wakinoue S; Chano T; Amano T; Isono T; Kimura F; Kushima R; Murakami T
Cancer Biomark; 2019; 24(2):223-229. PubMed ID: 30594917
[TBL] [Abstract][Full Text] [Related]
18. Analyzing the impact of ATF3 in tumorigenesis and immune cell infiltration of ovarian tumor: a bioinformatics study.
Li X; Liu P; Sun X; Ma R; Cui T; Wang T; Bai Y; Li Y; Wu X; Feng X
Med Oncol; 2021 Jul; 38(8):91. PubMed ID: 34216322
[TBL] [Abstract][Full Text] [Related]
19. Increased co-expression of MEST and BRCA1 is associated with worse prognosis and immune infiltration in ovarian cancer.
Zhang J; Yu S; Li Q; Wang Q; Zhang J
Gynecol Oncol; 2022 Mar; 164(3):566-576. PubMed ID: 35042621
[TBL] [Abstract][Full Text] [Related]
20. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
